Tenon Medical, Inc. (NASDAQ:TNON – Get Free Report) shares fell 2.4% during mid-day trading on Wednesday . The stock traded as low as $0.76 and last traded at $0.76. 13,263 shares were traded during trading, a decline of 90% from the average session volume of 136,713 shares. The stock had previously closed at $0.78.
Analysts Set New Price Targets
Separately, Benchmark lowered their price target on Tenon Medical from $5.00 to $3.00 and set a “speculative buy” rating on the stock in a research note on Monday, April 15th.
View Our Latest Analysis on TNON
Tenon Medical Stock Performance
Tenon Medical (NASDAQ:TNON – Get Free Report) last released its quarterly earnings data on Tuesday, May 14th. The company reported ($1.25) earnings per share for the quarter. Tenon Medical had a negative net margin of 445.77% and a negative return on equity of 1,267.31%. The company had revenue of $0.72 million during the quarter.
Tenon Medical Company Profile
Tenon Medical, Inc, a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints.
Featured Articles
- Five stocks we like better than Tenon Medical
- How to Calculate Inflation Rate
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- This Financial Stock’s Earnings Signal a Buying Opportunity
- Stock Average Calculator
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.